Electrochemotherapy for the Treatment of Vulvar Cancer

Status Recruiting

Clinical Trial Summary

Electrochemotherapy is a local treatment modality with effectiveness comparable to other local ablation techniques. With electrochemotherapy 80% objective response can be achieved and is suitable for the treatment of different types of tumors. The method is based on increased drug delivery to cells previously exposed to electroporation. The most commonly used cytotoxic agents are bleomycin and cisplatin. The aim of the proposed clinical trial is to determine the efficacy, feasibility and safety of electrochemotherapy in the treatment of vulvar cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05916690
Study type	Interventional
Source	Institute of Oncology Ljubljana
Contact	Maja Cemazar
Phone	+386-1-5879-544
Email	mcemazar@onko-i.si
Status	Recruiting
Phase	N/A
Start date	March 1, 2021
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00543543` - Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)	Phase 3
Completed	`NCT02096783` - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer	N/A
Completed	`NCT01986725` - The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence	Phase 2
Completed	`NCT03158220` - Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)	Phase 3
Completed	`NCT05372016` - Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	Phase 3
Recruiting	`NCT05743517` - Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)	N/A
Recruiting	`NCT05914974` - Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Recruiting	`NCT05979610` - Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies	Phase 2
Recruiting	`NCT04708470` - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers	Phase 1/Phase 2
Active, not recruiting	`NCT04357873` - Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations	Phase 2
Completed	`NCT00551187` - A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)	Phase 2
Completed	`NCT00520598` - Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)	Phase 2
Terminated	`NCT00669422` - ChemoFx® PRO - A Post-Market Data Collection Study	N/A
Completed	`NCT03676101` - Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	Phase 1
Not yet recruiting	`NCT06039111` - Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma	Phase 2
Recruiting	`NCT06127836` - Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer	N/A
Completed	`NCT04952961` - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	N/A
Completed	`NCT01806350` - Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors	N/A
Completed	`NCT00019110` - Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer	Phase 1
Recruiting	`NCT04141449` - A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation	Phase 2